Gene:
ADH5
alcohol dehydrogenase 5 (class III), chi polypeptide

PharmGKB contains no dosing guidelines for this gene. To report known dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this gene. To report a drug label with PGx, click here.

PharmGKB contains no clinical annotations for this gene. To report clinical variants, click here.

PharmGKB contains no genetic tests for this gene. To report genetic tests, click here.

Overview

Alternate Names:  Alcohol dehydrogenase (class III), chi polypeptide; FALDH; GSH-FDH; S-(hydroxymethyl)glutathione dehydrogenase; alcohol dehydrogenase (class III), chi polypeptide; alcohol dehydrogenase 5, chi polypeptide; alcohol dehydrogenase class chi chain; alcohol dehydrogenase class-3; alcohol dehydrogenase class-III; clutathione-dependent formaldehyde dehydrogenase; formaldehyde dehydrogenase; glutathione-dependent formaldehyde dehydrogenase
Alternate Symbols:  ADH-3; ADHX; FDH; GSNOR
PharmGKB Accession Id: PA24574

Details

Cytogenetic Location: chr4 : q23 - q23
GP mRNA Boundary: chr4 : 99992129 - 100009931
GP Gene Boundary: chr4 : 99989129 - 100019931
Strand: minus
Product Name: No data available
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

PharmGKB Curated Pathways

Pathways created internally by PharmGKB based primarily on literature evidence.

  1. Cyclophosphamide Pathway, Pharmacodynamics
    Model non-tissue-specific cancer cell displaying genes which may be involved in the cyclophosphamide pathway.

External Pathways

Links to non-PharmGKB pathways.

PharmGKB contains no links to external pathways for this gene. To report a pathway, click here.

Publications related to ADH5: 5

No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Influence of gene-gene interactions on response to albuterol therapy. Pharmacogenomics. 2011. Moore Paul E. [Article:21174616@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
The pharmacogenetics and pharmacogenomics of asthma therapy. The pharmacogenomics journal. 2011. Tse S M, et al. [Article:21987090@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol. Pharmacogenetics and genomics. 2010. Choudhry Shweta, et al. [Article:20335826@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. Human molecular genetics. 2007. Luo Xingguang, et al. [Article:17185388@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence. American journal of human genetics. 2006. Luo Xingguang, et al. [Article:16685648@PubMed]

LinkOuts

Entrez Gene:
128
OMIM:
103710
UCSC Genome Browser:
NM_000671
RefSeq RNA:
NM_000671
RefSeq Protein:
NP_000662
RefSeq DNA:
AC_000047
AC_000136
NC_000004
NT_016354
NW_001838915
NW_922162
HuGE:
ADH5
Comparative Toxicogenomics Database:
128
ModBase:
P11766
HumanCyc Gene:
HS10601
HGNC:
253

Common Searches

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.